Compare medicines
Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.
| Attribute | ||
|---|---|---|
| In short | New-generation drug for multidrug-resistant tuberculosis. | Cornerstone TB drug that turns body fluids orange. |
| Body system | Antibiotics | Antibiotics |
| Drug class | Anti-tuberculosis drugs | Anti-tuberculosis drugs |
| Supply | Prescription onlyWHO essential medicine | Prescription onlyWHO essential medicine |
| Main uses | Multidrug-resistant TB, Pre-extensively drug-resistant TB | Tuberculosis, Leprosy, Meningitis prevention in contacts, Prosthetic joint infections (with other drugs) |
| How it works | Blocks the energy-making machinery of TB bacteria. | Stops TB bacteria making RNA. |
| Starts working | Weeks | — |
| Half-life | About 5.5 months (terminal) | 2–5 hours |
| Typical adult dose | 400 mg once a day for 2 weeks, then 200 mg three times a week (6-month regimens are also used). | 10 mg/kg (usually 600 mg) once a day on an empty stomach, as part of combination therapy. |
| Forms | Tablet | Capsule, Oral suspension, Fixed-dose TB combination tablets, IV infusion |
| Common side effects | Nausea, Joint pain, Headache, Raised liver enzymes | Orange-red urine, sweat and tears, Nausea, Flu-like symptoms with intermittent dosing |
| Serious side effects | QT prolongation, Liver injury, Higher mortality signal in older trials | Liver injury, Low platelets, Kidney injury |
| Don't take if | QT prolongation; Severe liver disease; Use of rifampicin | — |
| Alcohol | Best avoided. Avoid alcohol; liver injury risk. | — |
| Pregnancy | Use with cautionLimited data; used when needed for resistant TB. | Generally considered safeTB treatment including rifampicin is recommended in pregnancy; vitamin K is given to the newborn. |
| Breastfeeding | Use with cautionLimited data; weigh against infant exposure. | — |
| In use since | — | 1968 |
| Brand names | United States: SirturoUnited Kingdom: SirturoIndia: Sirturo | United States: RifadinUnited Kingdom: Rifadin, RimactaneIndia: R-Cin, Rcinex (with isoniazid) |
| Legal status | United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H | — |
| ATC code | J04AK05 | J04AB02 |
Taken together
- ModerateBedaquiline + Rifampicin: Reduced effect
Enzyme induction lowers levels of this medicine, which may stop it working.